Cargando…

A Case of Lymphangioleiomyomatosis (LAM) of the Lung in a Patient with a History of Breast Cancer

Patient: Female, 47 Final Diagnosis: Lymphangioleiomyomatosis Symptoms: Dyspnea Medication: — Clinical Procedure: — Specialty: Pulmonology OBJECTIVE: Rare disease BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare progressive cystic and nodular disease of the lung characterized by smooth muscle ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koc-Günel, Sinem, Tekeli, Nesrin, Smaczny, Christina, Vogl, Thomas, Rohde, Gernot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446654/ https://www.ncbi.nlm.nih.gov/pubmed/30905927 http://dx.doi.org/10.12659/AJCR.914355

Ejemplares similares

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM)
por: Shen, Lisha, et al.
Publicado: (2021)

Pulmonary lymphangioleiomyomatosis (LAM): A literature overview and case report
por: Cong, Cung-Van, et al.
Publicado: (2022)

“Getting stuck with LAM”: patients perspectives on living with Lymphangioleiomyomatosis
por: Belkin, Amanda, et al.
Publicado: (2014)

LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment
por: Bernardelli, Clara, et al.
Publicado: (2022)

Sorafenib inhibits invasion of multicellular organoids that mimic Lymphangioleiomyomatosis nodules
por: Koc-Gunel, Sinem, et al.
Publicado: (2023)

Development of ATAQ-LAM: a tool to assess quality of life in Lymphangioleiomyomatosis
por: Walker, Tarik D., et al.
Publicado: (2015)

The Epidemiology and Clinical Features of Lymphangioleiomyomatosis (LAM): A Descriptive Study of 33 Case Reports
por: Shah, Jaini M, et al.
Publicado: (2023)

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009)

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
por: Gopalakrishnan, Vissagan, et al.
Publicado: (2018)

Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2019)

Estradiol Augments the Production and Actions of Polymorphonuclear Cells to Promote Lymphangioleiomyomatosis (LAM) Progression
por: Minor, Briaunna M N, et al.
Publicado: (2021)

MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013)

Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis
por: Gloeckl, Rainer, et al.
Publicado: (2020)

THU551 Glycoprotein-NMB (GPNMB) Is A Potential Lymphangioleiomyomatosis (LAM) Therapeutic Target And Biomarker
por: Gibbons, Erin, et al.
Publicado: (2023)

Correction: Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2020)

RF19 | PSUN351 Glycoprotein-NMB (GPNMB) is Pro-Tumorigenic in Lymphangioleiomyomatosis (LAM)
por: Gibbons, Erin, et al.
Publicado: (2022)

Sporadic uterine Lymphangioleiomyomatosis (LAM): Report of a unique case arising in the lower uterine segment with short review
por: Pongsuvareeyakul, Tip, et al.
Publicado: (2021)

A Quantitative Proteomic Approach to Identify Significantly Altered Protein Networks in the Serum of Patients with Lymphangioleiomyomatosis (LAM)
por: Banville, Nessa, et al.
Publicado: (2014)

Off-Pump Coronary Artery Bypass Grafting in a Patient with Lymphangioleiomyomatosis (LAM): Navigating the Perioperative Challenges
por: Kumar, Anand, et al.
Publicado: (2023)

OR34-5 Infiltrating Neutrophils and Neutrophil Elastase (NE) Promote Tumor Growth in a Mouse Model for Lymphangioleiomyomatosis (LAM)
por: Taya, Manisha, et al.
Publicado: (2019)

Lung Transplantation for Lymphangioleiomyomatosis in Japan
por: Ando, Katsutoshi, et al.
Publicado: (2016)

SAT-141 Glycoprotein NMB (GPNMB) Is Pro-Tumorigenic in TSC2-Null Cancer Cells and Is a Potential Drug Target and Biomarker for Lymphangioleiomyomatosis (LAM)
por: Gibbons, Erin, et al.
Publicado: (2020)

Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance
por: Yeoh, Zhao W, et al.
Publicado: (2014)

The lung microbiome in end-stage Lymphangioleiomyomatosis
por: Ng, Julie, et al.
Publicado: (2021)

SUN-134 Estrogen Induces Granulocytic Myeloid Derived Suppressor Cell Production to Potentially Modulate Lymphangioleiomyomatosis (LAM) Tumor Progression
por: Minor, Briaunna, et al.
Publicado: (2020)

Management of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2014)

Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis
por: Aghaeimeybodi, Fatemeh, et al.
Publicado: (2019)

The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis
por: Xu, Wenshuai, et al.
Publicado: (2021)

Study of breast cancer incidence in patients of lymphangioleiomyomatosis
por: Nuñez, Olivier, et al.
Publicado: (2016)

Primary abdominal lymphangioleiomyomatosis: report of a case
por: Ding, Yuan, et al.
Publicado: (2015)

Lymphangioleiomyomatosis: A Case Report and Review of Literature
por: Rhee, Jee Ah, et al.
Publicado: (2019)

Sporadic Lymphangioleiomyomatosis Disease: A Case Report
por: Nikmanesh, Yousef, et al.
Publicado: (2023)

Pulmonary lymphangioleiomyomatosis in a male.
por: Kang, H. W., et al.
Publicado: (1991)

Lymphangioleiomyomatosis: a clinical review
por: O'Mahony, Anne M., et al.
Publicado: (2020)

Coexistent sarcoidosis and lymphangioleiomyomatosis in a patient with cystic lung disease
por: Cullivan, Sarah, et al.
Publicado: (2018)

Lymphangioleiomyomatosis: A new relative contraindication for breast conservation therapy
por: Mallory, Matthew L., et al.
Publicado: (2017)

Multiple Cysts in the Kidney and Lungs in a Patient with Polycystic Kidney Disease and Lymphangioleiomyomatosis
por: Lam, Anna P., et al.
Publicado: (2007)

Role of Prolactin Receptors in Lymphangioleiomyomatosis
por: Alkharusi, Amira, et al.
Publicado: (2016)

Treatment of lymphangioleiomyomatosis and Camões
por: Rufino, Rogério
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m2vfrit0n9bhpc80dhqt169klr